Rossari Biotech Ltd
Fundamental Score
Rossari Biotech Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ROSSARI across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Excellent ROCE Performance (15.80%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Revenue Growth (17.61%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (28.23% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Strong Profit Growth Track Record (15.88% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.28)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (9.35x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (68.17%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
0 factors identified
No significant concerns identified in current analysis.
Financial Statements
Comprehensive financial data for Rossari Biotech Ltd
About ROSSARI
Business Overview
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it offers poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. Rossari Biotech Limited was founded in 1997 and is based in Mumbai, India.
Company Details
Key Leadership
Corporate Events
ROSSARI Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Rossari Biotech Ltd (ROSSARI)?
As of 09 Feb 2026, 12:23 pm IST, Rossari Biotech Ltd (ROSSARI) is currently trading at ₹538.75. The stock has a market capitalization of ₹3.32K (Cr).
Is ROSSARI share price Overvalued or Undervalued?
ROSSARI is currently trading at a P/E ratio of 24.31x, compared to the industry average of 29.20x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Rossari Biotech Ltd share price?
Key factors influencing ROSSARI's price include its quarterly earnings growth (Sales Growth: 17.61%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Rossari Biotech Ltd a good stock for long-term investment?
Rossari Biotech Ltd shows a 5-year Profit Growth of 15.88% and an ROE of 12.22%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.28 before investing.
How does Rossari Biotech Ltd compare with its industry peers?
Rossari Biotech Ltd competes with major peers in the Specialty Chemicals. Investors should compare ROSSARI's P/E of 24.31x and ROE of 12.22% against the industry averages to determine its competitive standing.
What is the P/E ratio of ROSSARI and what does it mean?
ROSSARI has a P/E ratio of 24.31x compared to the industry average of 29.20x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹24 for every ₹1 of annual earnings.
How is ROSSARI performing according to Bull Run's analysis?
ROSSARI has a Bull Run fundamental score of 53.6/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ROSSARI belong to?
ROSSARI operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Rossari Biotech Ltd.
What is Return on Equity (ROE) and why is it important for ROSSARI?
ROSSARI has an ROE of 12.22%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Rossari Biotech Ltd generates profits from shareholders' equity.
How is ROSSARI's debt-to-equity ratio and what does it indicate?
ROSSARI has a debt-to-equity ratio of 0.28, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is ROSSARI's dividend yield and is it a good dividend stock?
ROSSARI offers a dividend yield of 0.08%, which means you receive ₹0.08 annual dividend for every ₹100 invested.
How has ROSSARI grown over the past 5 years?
ROSSARI has achieved 5-year growth rates of: Sales Growth 28.23%, Profit Growth 15.88%, and EPS Growth 13.88%.
What is the promoter holding in ROSSARI and why does it matter?
Promoters hold 68.17% of ROSSARI shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ROSSARI's market capitalization category?
ROSSARI has a market capitalization of ₹3321 crores, placing it in the Small-cap category.
How volatile is ROSSARI stock?
ROSSARI has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ROSSARI?
ROSSARI has a 52-week high of ₹N/A and low of ₹N/A.
What is ROSSARI's operating profit margin trend?
ROSSARI has a 5-year average Operating Profit Margin (OPM) of 13.47%, indicating the company's operational efficiency.
How is ROSSARI's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 17.61% and YoY Profit Growth of 4.39%.
What is the institutional holding pattern in ROSSARI?
ROSSARI has FII holding of 2.70% and DII holding of 18.18%. Significant institutional holding often suggests professional confidence in the stock.